Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
|
TR |
|
Ayala Corp
OTC:AYYLF
|
PH |
Cash Flow Statement
Cash Flow Statement
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
485
|
348
|
443
|
612
|
443
|
532
|
336
|
180
|
172
|
123
|
(95)
|
(202)
|
(286)
|
(219)
|
(241)
|
(313)
|
(326)
|
(313)
|
|
| Depreciation & Amortization |
9
|
7
|
10
|
12
|
10
|
16
|
60
|
27
|
32
|
27
|
16
|
39
|
51
|
143
|
112
|
124
|
152
|
148
|
|
| Other Non-Cash Items |
28
|
14
|
(38)
|
(3)
|
1
|
(4)
|
(86)
|
(139)
|
(43)
|
(34)
|
58
|
3
|
92
|
240
|
240
|
181
|
194
|
265
|
|
| Cash Taxes Paid |
32
|
39
|
23
|
19
|
23
|
6
|
0
|
13
|
0
|
15
|
1
|
7
|
0
|
0
|
(2)
|
(0)
|
(0)
|
(0)
|
|
| Cash Interest Paid |
1
|
2
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(118)
|
(103)
|
(8)
|
(97)
|
(64)
|
(36)
|
(99)
|
34
|
5
|
(16)
|
36
|
110
|
72
|
(87)
|
(106)
|
(83)
|
(77)
|
87
|
|
| Cash from Operating Activities |
404
N/A
|
267
-34%
|
407
+53%
|
524
+29%
|
390
-26%
|
508
+30%
|
(135)
N/A
|
102
N/A
|
166
+63%
|
100
-39%
|
15
-85%
|
(87)
N/A
|
(70)
+19%
|
10
N/A
|
5
-54%
|
(54)
N/A
|
(58)
-7%
|
187
N/A
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(103)
|
(93)
|
(77)
|
(101)
|
(77)
|
(96)
|
(141)
|
(91)
|
(99)
|
(105)
|
(73)
|
(100)
|
(107)
|
(323)
|
(174)
|
(254)
|
(265)
|
(436)
|
|
| Other Items |
(238)
|
79
|
10
|
(29)
|
(29)
|
(190)
|
(71)
|
(41)
|
178
|
67
|
15
|
34
|
6
|
26
|
4
|
16
|
15
|
9
|
|
| Cash from Investing Activities |
(341)
N/A
|
(14)
+96%
|
(67)
-390%
|
(130)
-93%
|
(106)
+18%
|
(286)
-169%
|
(212)
+26%
|
(132)
+38%
|
78
N/A
|
(37)
N/A
|
(57)
-54%
|
(67)
-16%
|
(102)
-53%
|
(297)
-191%
|
(171)
+42%
|
(239)
-40%
|
(250)
-5%
|
(427)
-71%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
225
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
26
|
5
|
(26)
|
(26)
|
(26)
|
(4)
|
11
|
(5)
|
1
|
2
|
(2)
|
(17)
|
(14)
|
(15)
|
19
|
61
|
58
|
90
|
|
| Cash Paid for Dividends |
0
|
0
|
(210)
|
0
|
0
|
(306)
|
(585)
|
0
|
(436)
|
(130)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(201)
|
(268)
|
(2)
|
(157)
|
(156)
|
55
|
28
|
6
|
153
|
17
|
(5)
|
2
|
(14)
|
0
|
(1)
|
1
|
(1)
|
(15)
|
|
| Cash from Financing Activities |
(175)
N/A
|
(263)
-50%
|
(13)
+95%
|
43
N/A
|
43
+0%
|
(30)
N/A
|
(545)
-1 738%
|
(305)
+44%
|
(282)
+7%
|
(111)
+61%
|
(7)
+94%
|
115
N/A
|
101
-12%
|
(15)
N/A
|
18
N/A
|
62
+251%
|
58
-7%
|
75
+29%
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
(113)
N/A
|
(10)
+91%
|
327
N/A
|
437
+34%
|
327
-25%
|
192
-41%
|
(893)
N/A
|
(335)
+62%
|
(38)
+89%
|
(48)
-27%
|
(50)
-4%
|
(39)
+23%
|
(71)
-84%
|
(302)
-325%
|
(149)
+51%
|
(231)
-55%
|
(250)
-8%
|
(166)
+34%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
301
N/A
|
174
-42%
|
330
+90%
|
423
+28%
|
313
-26%
|
412
+32%
|
(277)
N/A
|
11
N/A
|
66
+507%
|
(4)
N/A
|
(58)
-1 221%
|
(187)
-222%
|
(178)
+5%
|
(313)
-76%
|
(169)
+46%
|
(308)
-82%
|
(323)
-5%
|
(249)
+23%
|
|